Phase III results of Lauriad presented at the 49th Annual ICAAC
Links shared publicly online about this topic.
- 1,746total visits
Phase III results of Lauriad presented at the 49th Annual ICAAC
BioAlliance Pharma has attended the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco to present results on miconazole Lauriad and anti-integrase inhibitor.
View full resource at news-medical.net
Tags: HIV, AIDS, STD, Chemotherapy, Pharma
Most Recently Shared on September 16, 2009 at 1:01 am By:
HIV/AIDS News: Phase III results of Lauriad presented at the 49th Annual ICAAC: BioAlliance Pharma.. http://bit.ly/3w5HAC
Advertisement
